We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Coffee, Decaffeinated Coffee, and Tea Consumption Linked to Lower Diabetes Risk

By HospiMedica International staff writers
Posted on 22 Dec 2009
High intakes of coffee, decaffeinated coffee, and tea are linked to a reduced risk of Type 2 Diabetes Mellitus, according to a pooled review of studies.

Researchers at the George Institute for International Health (Sydney, Australia), the University of Glasgow (United Kingdom), and other institutions conducted a systematic review and meta-analysis investigating the association among coffee, decaffeinated coffee, and tea consumption with the risk of diabetes mellitus. More...
The meta-analysis included data obtained from 18 studies that reported on the association between coffee consumption and diabetes; six studies that reported estimates of the association between decaffeinated coffee and diabetes; and seven studies that reported on the association of tea.

The results of the pooled meta-analysis found that drinking coffee was inversely related to risk of diabetes (more coffee was linked to lower risk). After adjusting for potential confounders, every extra cup of coffee consumed in a day was linked to a 7% reduction in the excess risk of diabetes; drinking 3 to 4 cups per day was linked to a 25% lower risk than drinking none or up to two cups per day. In those studies that assessed decaffeinated coffee consumption, drinking more than 3 to 4 cups a day was linked to about one third lower risk of diabetes, compared to none. Drinking more than 3 to 4 cups of tea per day was linked to a one fifth lower risk of diabetes, compared to non-tea drinking. The authors suggested the effect of tea and coffee consumption on diabetes risk could be due to direct biological effects, since their apparent protective effect appears to be independent of potential confounding variables, and could partly be due to other compounds present in tea and coffee, such as magnesium, or antioxidants such as lignans or chlorogenic acids. The study was published in the December 14, 2009, issue of the Archives on Internal Medicine.

"If such beneficial effects were observed in interventional trials to be real, the implications for the millions of individuals who have diabetes mellitus, or who are at future risk of developing it, would be substantial,” concluded first author Rachel Huxley, M.D., of the George Institute, and colleagues. "It could also be envisaged that we will advise our patients most at risk for diabetes mellitus to increase their consumption of tea and coffee in addition to increasing their levels of physical activity and weight loss.”

Related Links:

George Institute for International Health
University of Glasgow



Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Monitoring System
AlarmSense
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Amplatzer Paraclose PVL Occluder is a minimally invasive device for paravalvular leak closure, offering an alternative to repeat open-heart surgery. (Photo courtesy of Abbott)

FDA Approves First Transcatheter Device for Paravalvular Leak Closure

Paravalvular leak is a backflow of blood around a surgical heart valve that can follow valve replacement, causing heart failure symptoms or hemolysis. These leaks occur in 7%–17% of mitral valve replacements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences

Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

AI-Guided Echocardiography Enables Mobile Cardiac Imaging in Rural Communities

Echocardiography uses ultrasound to provide real-time images of cardiac structure and function, but access can be limited in rural communities where testing often depends on expert sonographers, imaging... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.